These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7993986)

  • 1. The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis.
    Bouley M; Tod M; Chavanet P; Petitjean O
    Biopharm Drug Dispos; 1994 Aug; 15(6):485-92. PubMed ID: 7993986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].
    Chavanet P; Charlier N; Brenet A; Goux A; Muggéo E; Caillot D; Casasnovas O; Kistermann JP; Waldner A; Portier H
    Pathol Biol (Paris); 1992 May; 40(5):507-12. PubMed ID: 1495835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.
    Joly V; Farinotti R; Saint-Julien L; Chéron M; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1994 Feb; 38(2):177-83. PubMed ID: 8192439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments concerning 'The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis'.
    Washington C; Davis SS
    Biopharm Drug Dispos; 1995 Aug; 16(6):529-31. PubMed ID: 7579034
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
    J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid.
    Shadkchan Y; Zaslavsky Z; Segal E
    Med Mycol; 2003 Feb; 41(1):15-9. PubMed ID: 12627800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.
    Shadkchan Y; Segal E
    J Antimicrob Chemother; 1999 Dec; 44(6):787-90. PubMed ID: 10590279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
    van Etten EW; Otte-Lambillion M; van Vianen W; ten Kate MT; Bakker-Woudenberg AJ
    J Antimicrob Chemother; 1995 Apr; 35(4):509-19. PubMed ID: 7628985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
    Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
    Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.
    Gondal JA; Swartz RP; Rahman A
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1544-8. PubMed ID: 2684010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
    Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
    Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental candidosis with amphotericin B-Intralipid admixtures in immunocompromised mice.
    Shadkchan Y; Segal E
    J Antimicrob Chemother; 2001 Aug; 48(2):245-51. PubMed ID: 11481296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
    Caillot D; Casasnovas O; Solary E; Chavanet P; Bonnotte B; Reny G; Entezam F; Lopez J; Bonnin A; Guy H
    J Antimicrob Chemother; 1993 Jan; 31(1):161-9. PubMed ID: 8444659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.